HDL subclasses and mortality in acute heart failure patients

Clin Chim Acta. 2019 Mar:490:81-87. doi: 10.1016/j.cca.2018.12.020. Epub 2018 Dec 19.

Abstract

The link between HDL subclasses and the prognosis of cardiovascular diseases remains controversial. We thus evaluated the prognostic value of the HDL subclasses 3 and 2 cholesterol (HDL3-C, HDL2-C) as well as of total HDL-C for 3-month mortality in acute heart failure (AHF) patients. The serum levels of HDL3-C and total HDL-C were determined by detergent-based homogeneous assay. HDL2-C was computed by the difference between total HDL-C and HDL3-C. Out of the 132 analyzed patients, 35 (26.5%) died within three months after onset of AHF. Univariate logistic regression analyses revealed a significant inverse association of HDL3-C (odds ratio (OR) 0.46 per 1-SD increase, 95% confidence interval (CI) 0.27-0.72, p = 0.001) with 3-month mortality, whereas concentrations of total HDL-C and HDL2-C showed no significant association. After adjustment for various laboratory and clinical parameters known to be associated with mortality in heart failure patients, HDL3-C concentrations remained significantly associated with 3-month mortality (OR 0.34 per 1-SD increase, 95% CI 0.15-0.74, p =0.010). We conclude that low admission serum levels of HDL3-C are associated with an increased 3-month mortality in AHF patients, whereas total HDL-C and HDL2-C showed no association. HDL3-C might thus be useful as a prognostic parameter in AHF.

Keywords: HDL particles; HDL3 cholesterol; Homogeneous assays; Outcome.

MeSH terms

  • Acute Disease
  • Aged
  • Aged, 80 and over
  • Cholesterol, HDL / blood*
  • Female
  • Heart Failure / blood*
  • Heart Failure / mortality*
  • Humans
  • Male
  • Middle Aged
  • Risk Factors

Substances

  • Cholesterol, HDL